14 results found.

Prostate Cancer Clinical Trial using Prostate Biopsy, Focal Brachytherapy , Assessment of QOL

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy Early Stage, Low Volume in Prostate Cancer.
Prostate Biopsy, Focal Brachytherapy , Assessment of QOL

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistan Clinical Trial using sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 18 years or older.
- Randomized Phase II Trial of Sipuleucel T Immunotherapy Preceded by Sensitizing Radiation Therapy and Sipuleucel-T Alone in Patients With Castrate Resistant Metastatic Prostate Cancer.
sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

Prostate Cancer, Hormone-resistant Prostate Cancer, Recurrent Pro Clinical Trial using laboratory biomarker analysis; questionnaire administration; doxorubicin-GnRH agonist conjugate AEZS-108

University of Southern California - Recruiting 18 years or older.
- A Phase I/II Trial of AN-152 [AEZS-108) in Castration- and Taxane-Resistant Prostate Cancer.
laboratory biomarker analysis; questionnaire administration; doxorubicin-GnRH agonist conjugate AEZS-108

Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate C Clinical Trial using cabazitaxel; prednisone; octreotide pamoate; questionnaire administration; octreotide acetate

University of Southern California - Recruiting 18 years or older.
- A Phase II Clinical Trial of Cabazitaxel Plus Prednisone With Octreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel.
cabazitaxel; prednisone; octreotide pamoate; questionnaire administration; octreotide acetate

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Pro Clinical Trial using stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 19 years or older.
- Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study.
stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Prostate Cancer, or Radiation Toxicity Clinical Trial using medical chart review; questionnaire administration; quality-of-life assessment; brachytherapy; radiation therapy

University of California, San Francisco - Recruiting N/A or older.
- Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer.
medical chart review; questionnaire administration; quality-of-life assessment; brachytherapy; radiation therapy

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Pro Clinical Trial using Akt inhibitor MK2206; bicalutamide; clinical observation

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Androgen Receptor Modulation Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy.
Akt inhibitor MK2206; bicalutamide; clinical observation

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Clinical Trial using cholecalciferol; genistein; placebo; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy.
cholecalciferol; genistein; placebo; laboratory biomarker analysis; pharmacological study

Prostate Cancer Clinical Trial using gonadotrophin releasing hormone; cyproterone acetate; quality-of-life assessment

National Cancer Institute (NCI) - Recruiting N/A to 79 years.
- Intermittent Hormone Therapy for Newly Diagnosed Metastatic Prostate Cancer.
gonadotrophin releasing hormone; cyproterone acetate; quality-of-life assessment

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage Clinical Trial using stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer.
stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Prostate Cancer Clinical Trial using bicalutamide; goserelin acetate; clinical observation

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III.
bicalutamide; goserelin acetate; clinical observation

Prostate Cancer Clinical Trial using flutamide; triptorelin; neoadjuvant therapy; radiation therapy

National Cancer Institute (NCI) - Recruiting N/A to 74 years.
- Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis.
flutamide; triptorelin; neoadjuvant therapy; radiation therapy

Breast Cancer, Depression, Long-term Effects of Cancer Treatment, Clinical Trial using educational intervention; informational intervention; internet-based intervention; questionnaire administration; study of socioeconomic and demographic variables; survey administration; psychosocial assessment and care; quality-of-life assessment

National Cancer Institute (NCI) - Recruiting N/A or older.
- Cancer Information Service Research Consortium: Years 2006-2011 Program Narrative and Overview.
educational intervention; informational intervention; internet-based intervention; questionnaire administration; study of socioeconomic and demographic variables; survey administration; psychosocial assessment and care; quality-of-life assessment

Prostate Cancer Clinical Trial using Taxotere; Celecoxib

Department of Veterans Affairs, New Jersey - Recruiting 18 years or older.
- A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer.
Taxotere; Celecoxib